Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 1154-1158, April 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dipple, A.
Right arrow Articles by Egan, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dipple, A.
Right arrow Articles by Egan, M.

Comparison of Metabolism-mediated Binding to DNA of 7-Hydroxymethyl-12-methylbenz(a)anthracene and 7,12-Dimethylbenz(a)anthracene1

A. Dipple2, J. E. Tomaszewski, R. C. Moschel, C. A. H. Bigger, J. A. Nebzydoski and M. Egan

Chemical Carcinogenesis Program, National Cancer Institute Frederick Cancer Research Center, Frederick, Maryland 21701

Comparison of the binding to DNA of 7-hydroxymethyl-12-methylbenz(a)anthracene and 7,12-dimethylbenz(a)anthracene (DMBA) catalyzed by mouse embryo cells in culture or by rat liver microsomes indicates that the products formed are different for the two hydrocarbons. Thus, the hydroxy compound is not an intermediate in the binding of DMBA to DNA in these systems.

Binding of the hydroxy compound to DNA in mouse embryo cells is less efficient than for DMBA and is inhibited by 1,1,1-trichloropropylene 2,3-oxide, an inhibitor of epoxide hydrase. This and the fluorescence spectra of the hydroxy compound-DNA adducts indicate that the hydroxy compound is activated for DNA binding through the formation of a diol-epoxide in the 1,2,3,4-ring. As previously found for DMBA, this is consistent with the activation of this compound through a bay-region diol-epoxide.

1 This work was sponsored by the National Cancer Institute under Contract N01-CO-75380 with Litton Bionetics, Inc.

2 To whom requests for reprints should be addressed, at Molecular Aspects of Chemical Carcinogenesis, Frederick Cancer Research Center, P. O. Box B, Frederick, Md. 21701.

Received 10/ 5/78. Accepted 12/21/78.




This article has been cited by other articles:


Home page
ScienceHome page
C. Bigger, J. Tomaszewski, A Dipple, and R. Lake
Limitations of metabolic activation systems used with in vitro tests for carcinogens
Science, July 25, 1980; 209(4455): 503 - 505.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.